Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 EUR | -0.34% |
|
+1.72% | -34.52% |
Jul. 01 | Abionyx Pharma: successful capital increase | CF |
Jun. 14 | Abionyx: positive response from FDA, share price rises | CF |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- ABNX Stock
- 609 Stock
- Revisions ABIONYX Pharma